CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $3.79B, above the global median of $1.14B
- FinancialsAltman Z-Score 1.63: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.79BUSDvs all stocks (USD)
Trailing P/E
39.33xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.86BUSDvs all stocks (USD)
Profit Margin
3.33%vs Medical Instruments & Supplies peers
Beta
0.8880xvs all stocks
52-Week Change
18.02%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
3.79BUSDvs all stocks (USD)
Enterprise Value
4.25BUSDvs all stocks (USD)
Trailing P/E
39.33xvs Medical Instruments & Supplies peers
Forward P/E
14.21xvs Medical Instruments & Supplies peers
PEG Ratio
0.3702xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.33xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.23xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.49xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
10.47xvs Medical Instruments & Supplies peers
Gross Margin
55.72%vs Medical Instruments & Supplies peers
Profit Margin
3.33%vs Medical Instruments & Supplies peers
Operating Margin
10.39%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.23%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.06%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.86BUSDvs all stocks (USD)
Revenue per Share (TTM)
17.41USDUpdated Oct 28, 2026Quarterly Revenue Growth
7.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.58BUSDvs all stocks (USD)
EBITDA (TTM)
444.20MUSDvs all stocks (USD)
Net Income (TTM)
95.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
103.40%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
302.60MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
267.89MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
2.72BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.23BUSDFY2025 · Dec 31, 2025Gross Profit
1.49BUSDFY2025 · Dec 31, 2025Operating Income
235.80MUSDvs all stocks (USD)
Pre-tax Income
177.20MUSDFY2025 · Dec 31, 2025Income Tax Expense
130.20MUSDFY2025 · Dec 31, 2025Net Income
47.00MUSDFY2025 · Dec 31, 2025EBIT
213.80MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
384.20MUSDFY2025 · Dec 31, 2025Research & Development
114.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.14BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
36.60MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.2800USDFY2025 · Dec 31, 2025EPS (Diluted)
0.2800USDFY2025 · Dec 31, 2025Basic Shares Outstanding
168.00MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
168.00MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
47.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
136.10MUSDFY2025 · Dec 31, 2025Free Cash Flow
91.30MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.21BUSDFY2025 · Dec 31, 2025Income Tax Paid
79.80MUSDFY2025 · Dec 31, 2025Interest Paid
46.10MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
47.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
150.70MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
11.40MUSDFY2025 · Dec 31, 2025Stock-based Compensation
37.60MUSDFY2025 · Dec 31, 2025Other Non-cash Items
4.20MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-48.50MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
7.50MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-73.80MUSDFY2025 · Dec 31, 2025Capital Expenditures
-44.80MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-9.90MUSDFY2025 · Dec 31, 2025Sale of Investments
10.40MUSDFY2025 · Dec 31, 2025Other Investing Activity
-6.80MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-51.10MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-116.30MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
115.40MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-166.60MUSDFY2025 · Dec 31, 2025Other Financing Charges
-6.20MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-173.70MUSDFY2025 · Dec 31, 2025Shares Outstanding
160.60MSharesUpdated Oct 28, 2026Float Shares
159.87MSharesUpdated Oct 28, 2026Shares Short
12.07MSharesUpdated Oct 28, 2026Short Ratio
4.12daysvs all stocks
Short % of Shares Outstanding
8.44%vs all stocks
% Held by Insiders
0.59%vs all stocks
% Held by Institutions
120.17%vs all stocks
Total Cash (MRQ)
1.13BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
7.01USDUpdated Oct 28, 2026Total Debt (MRQ)
1.59BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.5162xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.42xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
19.16USDUpdated Oct 28, 2026Total Assets
5.68BUSDvs all stocks (USD)
Total Current Assets
2.03BUSDFY2025 · Dec 31, 2025Total Liabilities
2.57BUSDFY2025 · Dec 31, 2025Total Non-current Assets
3.65BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.72BUSDFY2025 · Dec 31, 2025Total Current Liabilities
852.60MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.21BUSDFY2025 · Dec 31, 2025Accounts Receivable
429.60MUSDFY2025 · Dec 31, 2025Inventory
288.10MUSDFY2025 · Dec 31, 2025Accounts Payable
191.60MUSDFY2025 · Dec 31, 2025Short-term Debt
39.00MUSDFY2025 · Dec 31, 2025Deferred Revenue
184.80MUSDFY2025 · Dec 31, 2025Other Current Liabilities
97.60MUSDFY2025 · Dec 31, 2025Long-term Debt
1.56BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
12.00MUSDFY2025 · Dec 31, 2025Common Stock (Book)
1.80MUSDFY2025 · Dec 31, 2025Retained Earnings
-440.40MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
3.11BUSDvs all stocks (USD)
Treasury Stock
224.50MUSDFY2025 · Dec 31, 202552-Week Low
18.77USDUpdated Oct 28, 202652-Week High
30.42USDUpdated Oct 28, 202652-Week Change
18.02%vs all stocks
Beta
0.8880xvs all stocks
50-Day MA
24.97USDUpdated Oct 28, 2026200-Day MA
25.73USDUpdated Oct 28, 2026Avg 10-Day Volume
3.16MSharesUpdated Oct 28, 2026Avg 30-Day Volume
3.06MSharesUpdated Oct 28, 2026Diluted EPS (TTM)
0.6000USDUpdated Oct 28, 2026Other Income / Expense
-22.00MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Backed Earnings Configuration
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: 0.03
Financial Health
Altman Z-Score 1.63: grey zoneSignificant
Altman Z-Score: 1.63
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.79B, above the global median of $1.14BNotable
Market cap (USD): 3,787,365,578Global Median: 1,138,450,684.034
Revenue is $2.86B, above the global median of $562.3MNotable
Revenue (USD): 2,856,499,968Global Median: 562,304,852.367
Levered free cash flow is $267.89M, above the global median of $18.69MNotable
Levered free cash flow (USD): 267,887,504Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Pulse Biosciences Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Doral Group Renewable Energy Resources Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangsu Xinquan Automotive Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Sifang Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shanghai Moons' Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Stadler Rail AG
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xinyi Solar Holdings Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
ISA Energia Brasil S.A.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Trina Solar Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Diodes Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Tower Semiconductor Ltd.
1 interpretationCash-Backed Earnings Configuration
Tyson Foods Inc.
1 interpretationCash-Backed Earnings Configuration
Transcat Inc.
1 interpretationCash-Backed Earnings Configuration